Learn How to Start Conversations About Naloxone
The American Pharmacists Association (APhA) has just released a new resource aimed at helping pharmacists talk to their patients about naloxone use. As APhA reports, “coprescribing naloxone to patients taking opioids has been shown to significantly reduce opioid-related harms. Greater access to naloxone has been associated with 63% fewer emergency department visits and 27%–46% fewer opioid overdose deaths.”
Let’s Talk About Naloxone: It Saves Lives, developed by the APhA Academy of Pharmacy Practice & Management’s Pain, Palliative Care, and Addiction Special Interest Group, details when to consider naloxone for your patients, ways to initiate the conversation, communication tips, and more.
Related: Naloxone Access in Community Pharmacies; Surgeon General Urges More Americans to Carry Naloxone